Levetiracetam clinical trials
Also written AGB101.
How each study uses Levetiracetam is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study
Get an email when these change. Save the Levetiracetam studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.
See an example email
Example · made-up studies
Breast cancer · Recruiting: 2 came in, 3 changed
What changed in your alerts, Oct 31 – Nov 6:
A study of drug A after surgery for early breast cancer
Came in · now Recruiting
Drug B with hormone therapy in advanced breast cancer
Changed
· Sites: 4 added, including Seoul and Busan
· Enrollment: 300 → 450 participants
Exercise during chemotherapy
Now Active, not recruiting
One email a week for all your alerts. Stop any time.
Approvals
The first approval found in each region, with its record
- United States
- 30 Nov 1999 · KEPPRA · NDA 021035 (FDA, Drugs@FDA)
- European Union
- 29 Sept 2000 · Keppra · EMEA/H/C/000277 (EMA)
From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out
How studies write it
Studies that test it under each name
Studies by the year they started
203 studies that test it; most in 2007 (25)
| Year | Studies |
|---|---|
| 1998 | 1 |
| 1999 | 1 |
| 2000 | 2 |
| 2001 | 6 |
| 2002 | 5 |
| 2003 | 11 |
| 2004 | 12 |
| 2005 | 19 |
| 2006 | 13 |
| 2007 | 25 |
| 2008 | 6 |
| 2009 | 7 |
| 2010 | 4 |
| 2011 | 9 |
| 2012 | 4 |
| 2013 | 10 |
| 2014 | 4 |
| 2015 | 6 |
| 2016 | 1 |
| 2017 | 5 |
| 2018 | 6 |
| 2019 | 5 |
| 2020 | 5 |
| 2021 | 5 |
| 2022 | 1 |
| 2023 | 7 |
| 2024 | 6 |
| 2025 | 12 |
| 2026 | 5 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it, so a study counts once.
Who runs them
Industry 73 · Other 131
UCB Pharma (40) · UCB Japan Co. Ltd. (10) · Johns Hopkins University (4) · Teva Pharmaceuticals USA (4) · UCB Pharma SA (4) · Yale University (4) · Roxane Laboratories (4) · Duke University (4)
Often tested with
Tested in the same studies.
Valproic Acid (8) · Lamotrigine (8) · Phenytoin (7) · Lacosamide (7) · Phenobarbital (6) · Carbamazepine (5) · Fosphenytoin (4) · Zonisamide (4)
Coming up
From the study records. Dates are the sponsors’ own estimates and often move.
Reaching primary completion within a year · 8, 2 in phase 3
Studies that test Levetiracetam, phase 3 first.
- Jan 2027Levetiracetam for Seizure Prevention After Brain Tumor SurgeryPhase 3 · Beijing Tiantan Hospital
- Jun 2027Evaluation of Early Administration of Levetiracetam in the Prevention and Treatment Encephalopathy in Septic Shock: Randomized, Double-blind, Placebo-controlled TrialPhase 3 · Assistance Publique - Hôpitaux de Paris
- Dec 2026Clinical Trial Evaluating the Efficacy and Safety of AGB101 for Treatment of Parkinson's Disease Related PsychosisPhase 2 · Johns Hopkins University
- Feb 2027Levetiracetam as an Adjuvant Therapy to Hypothermia in Neonatal AsphyxiaNot applicable · Alexandria University
- Mar 2027Early Post-Traumatic Seizures Prevention Trial (E-PTS Trial)Phase 4 · All India Institute of Medical Sciences, Jodhpur
- Apr 2027Seizure Prevention in Traumatic Brain Injury With Levetiracetam and LacosamidePhase 4 · Wake Forest University Health Sciences
- May 2027Clinical Trial Evaluating the Efficacy of AGB101 for Reducing Hippocampal Overactivity in Older AdultsPhase 2 · Johns Hopkins University
- Jul 2027A Dose Escalation Study of Levetiracetam in the Treatment of Neonatal SeizuresPhase 2 · University of California, San Diego
Studies
Open first, then newest update. How each study uses Levetiracetam is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.
Testing it · 204
- Ketamine add-on Therapy for Established Status Epilepticus Treatment Trial (KESETT)RecruitingPhase 3University of VirginiaNCT06907173Written as Levetiracetam (LEV) (60 mg/Kg)
- Early Post-Traumatic Seizures Prevention Trial (E-PTS Trial)RecruitingPhase 4All India Institute of Medical Sciences, JodhpurNCT07072624Written as Levetiracetam
- Levetiracetam as an Adjuvant Therapy to Hypothermia in Neonatal AsphyxiaNot yet recruitingNot applicableAlexandria UniversityNCT07897032Written as Levetiracetam
- A Dose Escalation Study of Levetiracetam in the Treatment of Neonatal SeizuresRecruitingPhase 2University of California, San DiegoNCT05610085Written as Levetiracetam Injection
- Prophylactic Anti-Seizure Medication vs No Anti-Seizure Medication for Patients With Primary Motor Cortex Brain MetastasesRecruitingPhase 2Ayal A. Aizer, MDNCT07130786Written as Levetiracetam (Keppra)
- Seizure Treatment in GliomaRecruitingPhase 4Leiden University Medical CenterNCT03048084Written as Levetiracetam
- Investigating the Effect of a Single-dose of Levetiracetam on Brain Function, Chemistry and Cognitive Performance in Psychosis RiskRecruitingNot applicableKing's College LondonNCT06224530Written as Levetiracetam
- Levetiracetam for Seizure Prevention After Brain Tumor SurgeryRecruitingPhase 3Beijing Tiantan HospitalNCT07239115Written as Levetiracetam
- Seizure Prevention in Traumatic Brain Injury With Levetiracetam and LacosamideRecruitingPhase 4Wake Forest University Health SciencesNCT06866691Written as levetiracetam
- Levetiracetam Three Times Daily in EpilepsyRecruitingPhase 3Waad AlkathiriNCT07490769Written as Levetiracetam
- Short Versus Long-term Levetiracetam in Brain TumorsRecruitingPhase 3Tata Memorial CentreNCT06442748Written as Levetiracetam
- LEvetiracetam to Prevent Seizures in Symptomatic Alzheimer's Disease in Adults With Down SyndromeRecruitingPhase 3Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant PauNCT07234695Written as Levetiracetam 500mg
- Treatment of Seizures in Neonate With HIENot yet recruitingPhase 4Mansoura UniversityNCT07284498Written as Levetiracetam
- Levetiracetam Compared to Magnesium Sulfate for Prevention of Eclamptic SeizureNot yet recruitingPhase 3Nebraska Methodist Health SystemNCT07220902Written as Levetiracetam
- Levetiracetam Versus Phenobarbital in Benzodiazepines Unresponsive Paediatric Prolonged SeizuresRecruitingNot applicableMinistry of Health and Sports, MyanmarNCT07098728Written as Levetiracetam IV
- Early Initiated Ambulance-delivered Levetiracetam and Headposition in Hyper-acute Stroke TrialRecruitingPhase 3Shanghai East HospitalNCT06773364Written as Levetiracetam
- Evaluation of Early Administration of Levetiracetam in the Prevention and Treatment Encephalopathy in Septic Shock: Randomized, Double-blind, Placebo-controlled TrialNot yet recruitingPhase 3Assistance Publique - Hôpitaux de ParisNCT06851078Written as Levetiracetam IV
- Levetiracetam Prophylaxis in Brain Tumor Resection PilotNot yet recruitingPhase 3Hamilton Health Sciences CorporationNCT05897658Written as Levetiracetam
- Uncovering a Novel Therapeutic Target to Reduce Dementia Risk in Parkinson's DiseaseRecruitingPhase 2The University of QueenslandNCT04643327Written as Levetiracetam
- Improvement Effect of Lacosamide and Levetiracetam on Cognitive in Alzheimer's Disease Patients With EpilepsyRecruitingPhase 4Xiangya Hospital of Central South UniversityNCT05969054Written as Levetiracetam 250mg
See all 204 studies that test Levetiracetam →
Given beside what is tested · 13 — Levetiracetam is usual care or a partner of the new treatment
- Metabolically Fit CD19 CAR T Cells With CD34 Selection Markers in Adults With CD19-Positive B-Cell Acute Lymphocytic LeukemiaNot yet recruitingPhase 1Medical University of South CarolinaNCT07896213Written as Levetiracetam
- High Dose Ruxolitinib and Allogeneic Stem Cell Transplantation in Myelofibrosis Patients With SplenomegalyRecruitingPhase 2M.D. Anderson Cancer CenterNCT06345495Written as Levetiracetam
- Second or Greater Allogeneic Hematopoietic Stem Cell Transplant Using Reduced Intensity Conditioning (RIC)RecruitingNot applicableMasonic Cancer Center, University of MinnesotaNCT01666080Written as Keppra
- MT2021-08T Cell Receptor Alpha/Beta Depletion PBSC Transplantation for Heme MalignanciesRecruitingPhase 2Masonic Cancer Center, University of MinnesotaNCT05735717Written as Levetiracetam
- rAAV-Olig001-ASPA Gene Therapy for Treatment of Children With Typical Canavan DiseaseEnrolling by invitationPhase 1/2Myrtelle Inc.NCT04833907Written as Levetiracetam
- Ketamine and Levetiracetam as Second-line Antiseizure Medication for Status Epilepticus in ChildrenRecruitingPhase 2/3Sohag UniversityNCT07046611Written as Levetiracetam
- Therapy for Children With Advanced Stage NeuroblastomaCompletedPhase 2St. Jude Children's Research HospitalNCT01857934Written as levetiracetam
- Add on Lacosamide Versus High Dose MonotherapyCompletedPhase 3Brigham and Women's HospitalNCT01345058Written as levetiracetam
- Study Evaluating the Safety and Efficacy of KTE-C19 in Adult Participants With Refractory Aggressive Non-Hodgkin LymphomaCompletedPhase 1/2Kite, A Gilead CompanyNCT02348216Written as Levetiracetam
- Busulfan and Cyclophosphamide Followed By ALLO BMTTerminatedNot applicableMasonic Cancer Center, University of MinnesotaNCT01685411Written as Keppra
- A Study in Participants With Epilepsy, to Evaluate the Pharmacokinetics, Safety and Tolerability of Oxcarbazepine on PadsevonilCompletedPhase 1UCB Biopharma S.P.R.L.NCT03695094Written as Levetiracetam
- Non-Myeloablative Bone Marrow Transplant for Patients With Sickle Cell Anemia and Other Blood DisordersTerminatedPhase 2Sidney Kimmel Comprehensive Cancer Center at Johns HopkinsNCT00489281Written as Levetiracetam
- T-Cell Depleted Double UCB for Refractory AMLTerminatedPhase 2Masonic Cancer Center, University of MinnesotaNCT01464359Written as Levetiracetam
As the comparator · 6 — what is tested is compared with Levetiracetam
- A Study to Investigate the Safety of the Drugs Topiramate and Levetiracetam in Treating Children Recently Diagnosed With EpilepsyCompletedPhase 3Janssen Research & Development, LLCNCT02201251Written as Levetiracetam
- Generating Evidence on NonEpileptic, Stereotypical and Intermittent Symptoms (NESIS) in Chronic Subdural HematomasStatus unknownPhase 4Université de SherbrookeNCT04759196Written as Levetiracetam
- Modified Atkins Diet Versus Levetiracetam for Refractory Childhood EpilepsyStatus unknownPhase 2/3Lady Hardinge Medical CollegeNCT04172311Written as Levetiracetam
- To Demonstrate the Relative Bioavailability of Sandoz Inc. and UCB Pharma, Inc (Keppra) 750 mg Levetiracetam Tablets In Healthy Adults Volunteers Under Fasting ConditionsCompletedPhase 1SandozNCT00946751Written as Keppra (Levetiracetam) Tablets, 750 mg (UCB Pharma, Inc)
- Carisbamate Retention Study (CaReS): Comparative Study on the Long Term Effectiveness, Safety and Tolerability of Carisbamate Compared to Two Other Frequently Prescribed Anti-epileptic Drugs (AEDs) in Patients With Epilepsy.TerminatedPhase 3SK Life Science, Inc.NCT00563459Written as levetiracetam
- Clinical Study in Healthy Volunteers to Investigate the Neurocognitive Effects of a New Antiepileptic Drug: BrivaracetamCompletedPhase 1UCB PharmaNCT00736931Written as levetiracetam
What changed recently
From the registry's own updates since Oct 18, 2026.
Newly registered1
- Levetiracetam as an Adjuvant Therapy to Hypothermia in Neonatal AsphyxiaOct 27, 2026NCT07897032
Codes
What other systems call Levetiracetam · ClinicalTrials.gg INT006688
- MeSH (NLM) D000077287LevetiracetamConfirmed ClinicalTrials.gov, NLM
- UNII (FDA) 44YRR34555LEVETIRACETAMConfirmed FDA, NLM
- RxNorm 114477One source FDA
- NCI Thesaurus C47581LevetiracetamOne source FDA
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | D000077287 | Levetiracetam | Confirmed ClinicalTrials.gov, NLM |
| UNII (FDA) | 44YRR34555 | LEVETIRACETAM | Confirmed FDA, NLM |
| RxNorm | 114477 | — | One source FDA |
| NCI Thesaurus | C47581 | Levetiracetam | One source FDA |
Also registered as etiracetam (UNII 230447L0GL) and etiracetam, (r)- (UNII 73HC18Y1LW).
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.